Summary & Overview

Non-Extensive O.R. Procedures Unrelated to Principal Diagnosis with MCC: Inpatient Reimbursement Overview

DRG 987 addresses inpatient stays with non-extensive operating room procedures unrelated to the principal diagnosis when a Major Complication or Comorbidity is present, encompassing secondary surgical interventions that increase resource needs. Correct assignment is important for Medicare payment because the Major Complication or Comorbidity elevates the Diagnosis-Related Group relative weight and reimbursement to reflect greater clinical complexity.

Non-Extensive O.R. Procedures Unrelated to Principal Diagnosis with MCCDRG Non-Extensive O.R. Procedures Unrelated to Principal Diagnosis with MCCDRG 987Diagnosis-Related GroupInpatient ReimbursementMedicareSurgeryHospital CodingAcute Care

DRG 987 Overview

DRG 987 covers inpatient stays where a non-extensive operating room procedure that is unrelated to the principal diagnosis is performed and a Major Complication or Comorbidity is present. Typical cases involve secondary surgical procedures or interventions during a hospitalization for a different principal condition, with the Major Complication or Comorbidity driving higher resource use. This Diagnosis-Related Group matters for Medicare payment because the presence of a Major Complication or Comorbidity increases the relative weight and reimbursement to account for greater complexity and cost. Accurate coding of the principal diagnosis, secondary procedures, and the Major Complication or Comorbidity determines correct classification into DRG 987.

Clinical Trials

Acute perioperative safety and complication mitigation studies: randomized or observational studies evaluating protocols to reduce immediate postoperative complications (for example, enhanced monitoring, targeted infection prevention bundles, or optimized anticoagulation management) in patients undergoing non-extensive operative procedures that are not related to their principal diagnosis but who have major comorbid complications (MCC). These trials focus on the inpatient phase surrounding the unrelated O.R. procedure in a high-risk cohort (older adults, immunocompromised, or with severe cardiopulmonary disease) to quantify reductions in complications such as sepsis, postoperative bleeding, or respiratory failure. Findings are directly relevant to providers for optimizing perioperative care pathways and to payers by identifying interventions that may reduce length of stay and costly readmissions among DRG 987 admissions.
Comparative effectiveness research on procedural selection and timing in multimorbid patients: pragmatic trials or registry-based comparative studies comparing alternative minimally invasive versus open approaches, or immediate versus delayed scheduling of non-extensive O.R. procedures in patients whose primary admission diagnosis differs from the surgical indication and who carry MCCs. The population includes inpatients admitted for medical reasons who require an unrelated surgical intervention (e.g., bedside procedures, short operative cases) where clinicians must balance procedural benefit against risk from comorbidities. Results inform clinicians and health systems on which approaches yield lower inpatient morbidity, resource use, and costs for these complex cases, helping payers assess value and appropriate reimbursement pathways for DRG 987 encounters.
Post-discharge outcomes and care coordination studies: cohort studies and randomized transitional-care interventions testing post-discharge follow-up strategies, rehabilitation intensity, home health services, or telemonitoring to reduce readmissions and late complications after hospitalization involving a non-extensive unrelated procedure with MCC. These studies target survivors of the index hospitalization who are at high risk for adverse events after discharge due to their comorbid conditions and the added insult of an unrelated operative procedure. Evidence from this research is important to providers designing discharge plans and to payers aiming to lower downstream costs by preventing readmissions, prolonged recovery, and additional utilization associated with DRG 987 patients.

Clinical Trials

Acute perioperative safety and complication mitigation studies: randomized or observational studies evaluating protocols to reduce immediate postoperative complications (for example, enhanced monitoring, targeted infection prevention bundles, or optimized anticoagulation management) in patients undergoing non-extensive operative procedures that are not related to their principal diagnosis but who have major comorbid complications (MCC). These trials focus on the inpatient phase surrounding the unrelated O.R. procedure in a high-risk cohort (older adults, immunocompromised, or with severe cardiopulmonary disease) to quantify reductions in complications such as sepsis, postoperative bleeding, or respiratory failure. Findings are directly relevant to providers for optimizing perioperative care pathways and to payers by identifying interventions that may reduce length of stay and costly readmissions among DRG 987 admissions.
Comparative effectiveness research on procedural selection and timing in multimorbid patients: pragmatic trials or registry-based comparative studies comparing alternative minimally invasive versus open approaches, or immediate versus delayed scheduling of non-extensive O.R. procedures in patients whose primary admission diagnosis differs from the surgical indication and who carry MCCs. The population includes inpatients admitted for medical reasons who require an unrelated surgical intervention (e.g., bedside procedures, short operative cases) where clinicians must balance procedural benefit against risk from comorbidities. Results inform clinicians and health systems on which approaches yield lower inpatient morbidity, resource use, and costs for these complex cases, helping payers assess value and appropriate reimbursement pathways for DRG 987 encounters.
Post-discharge outcomes and care coordination studies: cohort studies and randomized transitional-care interventions testing post-discharge follow-up strategies, rehabilitation intensity, home health services, or telemonitoring to reduce readmissions and late complications after hospitalization involving a non-extensive unrelated procedure with MCC. These studies target survivors of the index hospitalization who are at high risk for adverse events after discharge due to their comorbid conditions and the added insult of an unrelated operative procedure. Evidence from this research is important to providers designing discharge plans and to payers aiming to lower downstream costs by preventing readmissions, prolonged recovery, and additional utilization associated with DRG 987 patients.

OpenPayer

Summary & Overview

Non-Extensive O.R. Procedures Unrelated to Principal Diagnosis with MCC: Inpatient Reimbursement Overview

DRG 987 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes